Literature DB >> 16095006

Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3.

H Schotte1, P Willeke, N Tidow, W Domschke, G Assmann, M Gaubitz, B Schlüter.   

Abstract

OBJECTIVE: To study the relative contribution of tumour necrosis factor (TNF) and HLA-DRB1 polymorphisms to the genetic susceptibility to systemic lupus erythematosus (SLE) via an extended haplotype analysis.
METHODS: We performed an association study in 205 unrelated German Caucasian patients with SLE fulfilling the 1997 revised American College of Rheumatology (ACR) criteria. Healthy age-, ethnically- and sex-matched individuals (n = 157) served as controls. HLA-DRB1 typing was performed by a sequence-specific oligonucleotide hybridisation assay. Two TNF single nucleotide polymorphisms (SNPs) and two multiallelic microsatellites were analysed by mutagenically separated polymerase chain reaction (PCR) or fragment length analysis, respectively. Extended haplotypes were reconstructed with the PHASE software.
RESULTS: Alleles for all polymorphic loci studied and the most frequent haplotypes showed a significantly different distribution between SLE patients and controls. The alleles HLA-DR2, DR3, TNFd1, TNF2, TNFB*1, and TNFa2, designated as risk alleles, and the extended haplotypes DR3-TNFd1-TNF2-TNFB*1-TNFa2 and DR2-TNFd3-TNF1-TNFB*2-TNFa11 prevailed in SLE patients. TNF risk alleles were strongly positively linked with HLA-DR3 and negatively linked with HLA-DR2. Thus, in HLA-DR3 haplotypes individual effects of TNF polymorphisms could not be resolved. By contrast, HLA-DR2 showed an association with SLE independently of TNF risk alleles, while the risk increased further when they were present. In haplotypes lacking HLA-DR2 and DR3, the alleles TNFdl and TNF2 contributed independently to SLE susceptibility.
CONCLUSION: Extended haplotype analysis revealed HLA-DR3 independent associations of TNF polymorphisms with susceptibility to SLE. Haplotypes that have been shown to be associated with different TNF-alpha production capacity may prevail in different disease subgroups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095006     DOI: 10.1080/03009740510017724

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  8 in total

1.  Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Hai-Feng Pan; Rui-Xue Leng; Chao Wang; Wei-Zi Qin; Li-Li Chen; Zhen-Qiu Zha; Jin-Hui Tao; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2011-04-16       Impact factor: 2.631

2.  Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.

Authors:  A M Abdou; X Gao; W Cozen; J R Cerhan; N Rothman; M P Martin; S Davis; M Schenk; S J Chanock; P Hartge; M Carrington; S S Wang
Journal:  Leukemia       Date:  2010-02-11       Impact factor: 11.528

3.  Meta-analysis of TNF-α promoter -308A/G polymorphism and SLE susceptibility in Asian populations.

Authors:  Yan-Feng Zou; Xiao-Liang Feng; Jin-Hui Tao; Hong Su; Fan-Ming Pan; Fang-Fang Liao; Ye Fan; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2010-03-24       Impact factor: 2.631

Review 4.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

5.  Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

Authors:  Christine F Skibola; Paige M Bracci; Alexandra Nieters; Angela Brooks-Wilson; Silvia de Sanjosé; Ann Maree Hughes; James R Cerhan; Danica R Skibola; Mark Purdue; Eleanor Kane; Qing Lan; Lenka Foretova; Maryjean Schenk; John J Spinelli; Susan L Slager; Anneclaire J De Roos; Martyn T Smith; Eve Roman; Wendy Cozen; Paolo Boffetta; Anne Kricker; Tongzhang Zheng; Tracy Lightfoot; Pierluigi Cocco; Yolanda Benavente; Yawei Zhang; Patricia Hartge; Martha S Linet; Nikolaus Becker; Paul Brennan; Luoping Zhang; Bruce Armstrong; Alex Smith; Renee Shiao; Anne J Novak; Marc Maynadie; Stephen J Chanock; Anthony Staines; Theodore R Holford; Elizabeth A Holly; Nathaniel Rothman; Sophia S Wang
Journal:  Am J Epidemiol       Date:  2010-01-04       Impact factor: 4.897

6.  Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic.

Authors:  Siavash Nasiri; Mansoor Karimifar; Zahra Sayed Bonakdar; Mansour Salesi
Journal:  Rheumatol Int       Date:  2009-10-07       Impact factor: 2.631

Review 7.  Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.

Authors:  Manfred Relle; Andreas Schwarting
Journal:  Clin Dev Immunol       Date:  2012-06-19

8.  British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.

Authors:  Chee-Seng Yee; Vernon Farewell; David A Isenberg; Anisur Rahman; Lee-Suan Teh; Bridget Griffiths; Ian N Bruce; Yasmeen Ahmad; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; David D'Cruz; Munther A Khamashta; Peter Maddison; Caroline Gordon
Journal:  Arthritis Rheum       Date:  2007-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.